High Net Worth Advisory Group LLC Cyclerion Therapeutics, Inc. Transaction History

High Net Worth Advisory Group LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	BUY	$0.96 - $1.78 $480 - $890	500 Added 100.0%	1,000 $1,000
Q4 2021 Aug 10, 2022	SELL	$1.56 - $2.99 $780 - $1,495	-500 Reduced 50.0%	500 $1,000
Q4 2021 Apr 27, 2022	BUY	$1.56 - $2.99 $1,560 - $2,990	1,000 New	1,000 $2,000

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $109M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of High Net Worth Advisory Group LLC, based on Form 13F filings with the SEC.

Stay updated on High Net Worth Advisory Group LLC with notifications on news.